Literature DB >> 27801454

Reversibility of the thia-Michael reaction of cytotoxic C5-curcuminoid and structure-activity relationship of bis-thiol-adducts thereof.

Aki Kohyama1, Michihiro Fukuda, Shunsuke Sugiyama, Hiroyuki Yamakoshi, Naoki Kanoh, Chikashi Ishioka, Hiroyuki Shibata, Yoshiharu Iwabuchi.   

Abstract

C5-curcuminoids [a.k.a. bis(arylmethylidene)acetones] are curcumin analogues bearing a reactive cross-conjugated dienone structure essential for eliciting cytotoxicity. To gain insight into the mode of action of C5-curcuminoids, we investigated the reversibility of the thia-Michael reaction of 1,5-bis(3,5-bis(methoxymethoxy)phenyl)-1,4-pentadiene-3-one, named GO-Y030 which is the most potent cytotoxic C5-curcuminoid, using spectroscopic methods. A panel of GO-Y030-bis-thiol-adducts were synthesized and the structure-reactivity relationship regarding the retro thia-Michael reaction as well as the cell growth inhibitory activity against human colon cancer HCT116 were evaluated. Some C5-curcuminoid thiol-adducts exhibited comparable cytotoxicity with GO-Y030, demonstrating their potential use as prodrugs. These results imply that C5-curcuminoids elicit cytotoxicity by covalently interacting with various biothiols via a reversible thia-Michael reaction.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27801454     DOI: 10.1039/c6ob01771a

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  4 in total

1.  Synthetic Analogs of Curcumin Modulate the Function of Multidrug Resistance-Linked ATP-Binding Cassette Transporter ABCG2.

Authors:  Megumi Murakami; Shinobu Ohnuma; Michihiro Fukuda; Eduardo E Chufan; Katsuyoshi Kudoh; Keigo Kanehara; Norihiko Sugisawa; Masaharu Ishida; Takeshi Naitoh; Hiroyuki Shibata; Yoshiharu Iwabuchi; Suresh V Ambudkar; Michiaki Unno
Journal:  Drug Metab Dispos       Date:  2017-09-13       Impact factor: 3.922

2.  Curcumin analog, GO-Y078, overcomes resistance to tumor angiogenesis inhibitors.

Authors:  Kazuhiro Shimazu; Masahiro Inoue; Shunsuke Sugiyama; Koji Fukuda; Taichi Yoshida; Daiki Taguchi; Yoshihiko Uehara; Sei Kuriyama; Masamitsu Tanaka; Masatomo Miura; Hiroshi Nanjyo; Yoshiharu Iwabuchi; Hiroyuki Shibata
Journal:  Cancer Sci       Date:  2018-08-16       Impact factor: 6.716

3.  BP-M345, a New Diarylpentanoid with Promising Antimitotic Activity.

Authors:  Pedro Novais; Patrícia M A Silva; Joana Moreira; Andreia Palmeira; Isabel Amorim; Madalena Pinto; Honorina Cidade; Hassan Bousbaa
Journal:  Molecules       Date:  2021-11-25       Impact factor: 4.411

4.  Pyrazole-Curcumin Suppresses Cardiomyocyte Hypertrophy by Disrupting the CDK9/CyclinT1 Complex.

Authors:  Masafumi Funamoto; Yoichi Sunagawa; Mai Gempei; Kana Shimizu; Yasufumi Katanasaka; Satoshi Shimizu; Toshihide Hamabe-Horiike; Giovanni Appendino; Alberto Minassi; Andreas Koeberle; Maki Komiyama; Kiyoshi Mori; Koji Hasegawa; Tatsuya Morimoto
Journal:  Pharmaceutics       Date:  2022-06-15       Impact factor: 6.525

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.